Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Pfizer

company

About

Pfizer is a pharmaceuticals and biotechnology company that supports wellness and prevention

Details

Last Funding Type
IPO
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 1849
Number Of Employee
10001 - max
Operating Status
Active
Stock Symbol
nyse:PFE
Legal Name
Pfizer Inc.

Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Pfizer has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 13, 1978 from a IPO round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 13, 1978 IPO Detail

Investments

Number of Investments
Number of Lead Investments
44
19
Pfizer has made 44 investments. Their most recent investment was on Dec 21, 2022, when ORIC Pharmaceuticals raised $25M.
Date Company Name
Round Money Raised Industry Lead Investor
Post-IPO Equity $25M Biotechnology Yes
Series C $60M Biotechnology Yes
Sep 20, 2022 CytoReason
Corporate Round $20M Biopharma Yes
Jun 20, 2022 Valneva
Post-IPO Equity €90.50M Biotechnology Yes
Jun 14, 2022 Dren Bio
Series B $65M Biotechnology

Employee Profiles

Number of Employee Profiles
144
Pfizer has 144 current employee profiles, including Board member Shantanu Narayen
Board member
Board member
Executive
Executive

Exits

Pfizer has had 18 exits. Pfizer most notable exits include LianBio ,   Sema4

Date Company Name Exit Type Industry
Nov 1, 2021 LianBio IPO Biopharma Detail
Jul 23, 2021 Sema4 IPO Artificial Intelligence Detail
May 6, 2021 Valneva IPO Biotechnology Detail
Apr 28, 2021 Amplyx Pharmaceuticals M&A Biotechnology Detail
Oct 28, 2020 Cerevel Therapeutics IPO Biotechnology Detail

Acquisition

Pfizer has acquired 38 organizations. Their most recent acquisition was Warner-Lambert on Feb 7, 2000. They acquired Warner-Lambert for $90B.

Date Company Name
Industry Acquisition Type Price
Feb 7, 2000 Warner-Lambert
Biotechnology acquisition $ 90B Detail
Jul 15, 2002 Pharmacia
Biotechnology Detail
Dec 21, 2003 Esperion
Biotechnology acquisition $ 1.30B Detail
Jan 21, 2005 Angiosyn
Biotechnology acquisition Detail
Biopharma acquisition Detail